| Date | Time | Source | Headline | Symbol | Company |
| 05/14/2009 | 10:35AM | PR Newswire (US) | Amylin Issues Statement Regarding Open Letter From Icahn | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 9:29AM | PR Newswire (US) | Icahn Issues Open Letter to Amylin Shareholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 6:07AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/14/2009 | 6:04AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/13/2009 | 5:03PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/12/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Deutsche Bank Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/12/2009 | 3:07PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/12/2009 | 12:14PM | Business Wire | Eastbourne Capital Sends Letter to Amylin Pharmaceuticals Shareholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/12/2009 | 12:02PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/11/2009 | 4:15PM | PR Newswire (US) | Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate | NASDAQ:AMLN | |
| 05/11/2009 | 10:26AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/11/2009 | 9:25AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/11/2009 | 9:01AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/11/2009 | 9:00AM | PR Newswire (US) | Amylin Sends Letter To Shareholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/07/2009 | 5:30PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2009 | 5:04PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2009 | 12:17PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2009 | 8:00AM | Business Wire | Eastbourne Capital Files Presentation Outlining the Case for Change at Amylin Pharmaceuticals | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/06/2009 | 7:05AM | Edgar (US Regulatory) | Proxy Statment - Contested Solicitations (definitive) (DEFC14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/05/2009 | 5:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/05/2009 | 2:28PM | PR Newswire (US) | Stock Alerts on Newsworthy Market Movers: CVS, KFT, THC, WY, AMLN, WYNN; Issued by Beacon Equity | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/05/2009 | 8:00AM | PR Newswire (US) | Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/04/2009 | 5:29PM | Dow Jones News | Amylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10 | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/04/2009 | 4:30PM | PR Newswire (US) | Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/04/2009 | 12:40PM | Edgar (US Regulatory) | Proxy Statment - Contested Solicitations (definitive) (DEFC14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/04/2009 | 9:40AM | Marketwired | AnalystChoice.com Free Investment Opinion on CMCSK, BRCD, ACAS and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2009 | 11:11AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/01/2009 | 9:30AM | PR Newswire (US) | Amylin Sends Letter to Shareholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/30/2009 | 2:55PM | Dow Jones News | DEALWATCH: Lilly Can't Afford To Double Down With Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/29/2009 | 4:43PM | PR Newswire (US) | Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |